NOT-CA-24-090: Notice to Extend Expiration Date for PAR-21-321, Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Notice to Extend Expiration Date for PAR-21-321, Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Notice Number:

NOT-CA-24-090

Key Dates

Release Date:

August 12, 2024

Related Announcements

October 12, 2021 - Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional. See PAR-21-321

Issued by

National Cancer Institute (NCI)

Purpose

This purpose of this notice is to extend the expiration date for PAR-21-321, “Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional).”

The following section of PAR-21-321 has been modified:

Key Dates

Currently reads:

Expiration Date

January 08, 2025

Changed to read (in italics)

Expiration Date

January 08, 2026

All other aspects of PAR-21-321 remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)
Office of Cancer Centers
National Cancer Institute (NCI)
Telephone: 240-276-5600
Email: ncicenters-r@mail.nih.gov

Peer Review Contact(s)
Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: ncirefof@dea.nci.nih.gov

Financial/Grants Management Contact(s)
Office of Grants Administration
National Cancer Institute (NCI)
Telephone: 240-276-6277